Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.
about
Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms.Inhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot studyEvolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa.Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infectionPseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomesDiseases of the nose and paranasal sinuses in child.SNaPaer: a practical single nucleotide polymorphism multiplex assay for genotyping of Pseudomonas aeruginosa.Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis.Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosaChanges of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyLong-term social dynamics drive loss of function in pathogenic bacteria.The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.Bacterial Pathogens and the Microbiome.Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis.Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory SpecimensEffect of infectious dose and season on development of hemorrhagic pneumonia in mink caused by Pseudomonas aeruginosaBile signalling promotes chronic respiratory infections and antibiotic toleranceRapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures.Bacterial pathogens: from natural ecosystems to human hosts.The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.Staphylococcus aureus in early cystic fibrosis lung disease.Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis.Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.Cystic fibrosis: a clinical view.
P2860
Q27331155-AC25C509-E630-48AD-9777-F529CBDF05A5Q28077482-E1DD4C55-F09A-4924-90C9-BEB9BBC63E1AQ30442057-281DB314-7560-4235-A265-8E2B6A3CDABBQ30539692-06219A5A-EC34-4E63-B3D0-314BF7E51B2DQ33624180-F152B26F-E19E-4B23-A832-063F35ADDD2EQ34082906-632AD2FA-258A-46EB-9D7A-E7FF2E90151DQ34106186-C3A7B9EC-A2BF-4352-8519-BBDD75173282Q34229846-AF3725D8-A5D0-487E-8DBD-4528E4D7031FQ34479389-3008EF53-EACD-4585-A7B2-B408F23CA54EQ34480377-76C7C810-ECE3-4EF1-A5D2-9BDE120CD0D0Q34751071-49533F75-41F0-492D-9D7C-4635F0161B9EQ34776249-5EF36151-E2F9-461D-A6E8-F83D4D02AB77Q35023645-B828A386-3772-421D-BF44-221BFEA6B971Q35043722-4CD79988-0501-45F1-8EC4-34B04E72F8D5Q35239067-45A3E132-A7DE-4840-80AD-B248220F2EA8Q35763672-F2150745-4E1B-426E-B3F0-A25D583ED240Q35800789-48C808F3-ED2D-4873-BECC-1BD0AE684EC7Q35817400-A554654F-3F7B-4100-B39F-4A813C725534Q36008300-910DCE8F-DC2C-41AE-B2A8-EC27BC3453C4Q36046509-3698064A-5A75-46C0-823B-2538548C4CAEQ36099548-F41ED402-1854-44F2-9119-36CCBD3175B2Q36135733-62CAE07D-901E-4F80-B2A9-7498031139A2Q36204569-E5C50BCE-B2E3-4DE7-B6C5-382F17F4C1ACQ36226940-B4168F83-2393-4732-BBB5-6DCD42F61733Q36373272-FD1DE94C-034B-4E7D-BC42-8A944DEF2F2FQ36620854-6FF23AC5-1700-4B90-A4EA-F8E85FA72F11Q36979454-83DE1F6E-C6BD-45A8-AF8B-9FF42A6CD1B9Q37105133-EB7B053E-54F5-4C94-B517-7CF80D54B86DQ37589273-9B793726-7DEE-4773-B2BC-3359DB784279Q37691811-00B23C0E-C575-452B-AB9F-7612DA252800Q38031603-D02EC067-A87C-4DB4-A7E3-C97AE335441BQ38130513-75A24B81-CCFF-41EC-897A-441F48413EFEQ38130897-6A1F0650-68DD-443A-8BA8-61FA1296FC44Q38268531-02F403CF-D7B7-4570-9599-67A24D82A851Q38273318-94D469E9-0A02-4B4E-81A3-CE1B30623D90Q38358624-67B88995-F7B5-458F-A7AD-4BDF275B36D9Q38541804-D8FB1D9B-512E-4033-B814-F67B3D2DA26CQ38599404-2A53A670-8114-4911-A900-496CD84993C4Q38833703-5E6C5C02-8867-4674-BAB2-9A384B47D84CQ38973292-410F6AF4-430E-4251-80F1-93A59F08DB7C
P2860
Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Evolution and diversification ...... ns for chronic lung infection.
@en
Evolution and diversification ...... ns for chronic lung infection.
@nl
type
label
Evolution and diversification ...... ns for chronic lung infection.
@en
Evolution and diversification ...... ns for chronic lung infection.
@nl
prefLabel
Evolution and diversification ...... ns for chronic lung infection.
@en
Evolution and diversification ...... ns for chronic lung infection.
@nl
P2093
P2860
P50
P356
P1433
P1476
Evolution and diversification ...... ns for chronic lung infection.
@en
P2093
Hanne Østergaard Jarmer
Kasper Aanæs
Martin Holm Rau
Susse Kirkelund Hansen
P2860
P2888
P356
10.1038/ISMEJ.2011.83
P50
P577
2011-06-30T00:00:00Z